| Literature DB >> 6093009 |
Abstract
Neuroblastoma-glioma NG108-15 cells that were cultured for 48 h with the opiate antagonist, naloxone, respond to the guanosine 5'-triphosphate (GTP) analogue guanosine 5'-[beta, gamma-imido]-triphosphate (GMP-PNP) in the binding assay as the control, non-treated, cells. This was observed when the guanyl nucleotide was tested in the presence or absence of sodium chloride and also after subcellular fractionation of the membranes on a sucrose gradient which separated between two receptor-containing fractions. The findings suggest that the increase in delta type enkephalin receptors in naloxone-treated NG108-15 cells does not reflect an alteration in the interaction between the receptor and the adenylate cyclase-GTP-binding protein system.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6093009 DOI: 10.1016/0304-3940(84)90475-0
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046